These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 24360309
1. [Fluoroquinolones to prevent bacterial infection in children with chemotherapy induced neutropenia: is it reasonable?]. Dubos F, Delebarre M, Lagrée M. Arch Pediatr; 2013 Nov; 20 Suppl 3():S90-3. PubMed ID: 24360309 [Abstract] [Full Text] [Related]
3. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G, Allione B, D'Antonio D, Buelli M, Nosari AM, Cilloni D, Zuffa E, Cantaffa R, Specchia G, Amadori S, Fabbiano F, Deliliers GL, Lauria F, Foà R, Del Favero A, Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Infection Program. N Engl J Med; 2005 Sep 08; 353(10):977-87. PubMed ID: 16148283 [Abstract] [Full Text] [Related]
4. Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider. Lo N, Cullen M. Hematol Oncol; 2006 Sep 08; 24(3):120-5. PubMed ID: 16783844 [Abstract] [Full Text] [Related]
5. Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia. Verlinden A, Jansens H, Goossens H, van de Velde AL, Schroyens WA, Berneman ZN, Gadisseur AP. Eur J Haematol; 2014 Oct 08; 93(4):302-8. PubMed ID: 24750350 [Abstract] [Full Text] [Related]
6. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia]. Qin TJ, Mi YC, Feng SZ, Li DP, Wei JL, Yang DL, Han MZ, Wang JX, Bian SG. Zhonghua Yi Xue Za Zhi; 2007 May 29; 87(20):1389-93. PubMed ID: 17785058 [Abstract] [Full Text] [Related]
7. The conundrum of fluoroquinolone prophylaxis. Freifeld A, Sepkowitz K. Nat Clin Pract Oncol; 2006 Oct 29; 3(10):524-5. PubMed ID: 17019427 [No Abstract] [Full Text] [Related]
8. Cefpodoxime for antimicrobial prophylaxis in neutropenia: a retrospective case series. Wojenski DJ, Barreto JN, Wolf RC, Tosh PK. Clin Ther; 2014 Jun 01; 36(6):976-81. PubMed ID: 24832560 [Abstract] [Full Text] [Related]
9. Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee. Slavin MA, Lingaratnam S, Mileshkin L, Booth DL, Cain MJ, Ritchie DS, Wei A, Thursky KA, Australian Consensus Guidelines 2011 Steering Committee. Intern Med J; 2011 Jan 01; 41(1b):102-9. PubMed ID: 21272174 [Abstract] [Full Text] [Related]
10. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City]. Ugarte-Torres A, Villasis-Keever A, Hernández-Bribiesca ME, Crespo-Solis E, Ruiz-Palacios GM, Sifuentes-Osornio J, Ponce-De-León-Garduño A. Rev Invest Clin; 2006 Jan 01; 58(6):547-54. PubMed ID: 17432285 [Abstract] [Full Text] [Related]
11. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Gafter-Gvili A, Fraser A, Paul M, Leibovici L. Ann Intern Med; 2005 Jun 21; 142(12 Pt 1):979-95. PubMed ID: 15968013 [Abstract] [Full Text] [Related]
12. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia. Mayer K, Hahn-Ast C, Mückter S, Schmitz A, Krause S, Felder L, Bekeredjian-Ding I, Molitor E, Brossart P, von Lilienfeld-Toal M. Support Care Cancer; 2015 May 21; 23(5):1321-9. PubMed ID: 25617073 [Abstract] [Full Text] [Related]
13. Safe fluoroquinolones prophylaxis in blood cancer patients with chemotherapy-induced neutropenia and Glucose-6-Phosphate-Dehydrogenase deficiency. Sanna M, Caocci G, Orrù F, Ledda A, Vacca A, Piras E, Fozza C, Deias P, Tidore G, Dore F, La Nasa G. J Clin Pharm Ther; 2017 Dec 21; 42(6):733-737. PubMed ID: 28597476 [Abstract] [Full Text] [Related]
14. Antibacterial prophylaxis in neutropenic patients. Viscoli C. Int J Antimicrob Agents; 2007 Nov 21; 30 Suppl 1():S60-5. PubMed ID: 17706926 [Abstract] [Full Text] [Related]
15. Predicting the risk of severe infection in children with chemotherapy-induced febrile neutropenia. Dubos F, Delebarre M, Martinot A. Curr Opin Hematol; 2012 Jan 21; 19(1):39-43. PubMed ID: 22123661 [Abstract] [Full Text] [Related]
16. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies. Reuter S, Kern WV, Sigge A, Döhner H, Marre R, Kern P, von Baum H. Clin Infect Dis; 2005 Apr 15; 40(8):1087-93. PubMed ID: 15791505 [Abstract] [Full Text] [Related]
17. Antibiotic prophylaxis in neutropenic children with acute leukemia: Do the presently available data really support this practice? Calitri C, Ruberto E, Castagnola E. Eur J Haematol; 2018 Dec 15; 101(6):721-727. PubMed ID: 30107054 [Abstract] [Full Text] [Related]
18. Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity. Martino R, Subira M, Altés A, López R, Sureda A, Domingo-Albós A, Pericas R, Brunet S. Acta Haematol; 1998 Dec 15; 99(4):206-11. PubMed ID: 9644298 [Abstract] [Full Text] [Related]
19. Use of fluoroquinolones as prophylactic agents in patients with neutropenia. Patrick CC. Pediatr Infect Dis J; 1997 Jan 15; 16(1):135-9; discussion 160-2. PubMed ID: 9002124 [Abstract] [Full Text] [Related]
20. [Prophylaxis with fluoroquinolones in patients with neutropenia]. Brodsky AL, Minissale CJ, Melero MJ, Sánchez Avalos JC. Medicina (B Aires); 1993 Jan 15; 53(5):401-7. PubMed ID: 8201928 [Abstract] [Full Text] [Related] Page: [Next] [New Search]